Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-13 Sale | 2024-05-14 4:05 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 12,016 | $1.26 | $15,140 | 651,243 (Direct) | View |
| 2024-02-29 Sale | 2024-03-01 5:48 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 5,974 | $1.58 | $9,439 | 663,259 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:03 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 7,411 | $1.52 | $11,265 | 669,233 (Direct) | View |
| 2023-05-25 Sale | 2023-05-25 9:01 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 63,186 | $1.2229 | $77,270 | 724,344 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 13,034 | $0.8775 | $11,437 | 287,530 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:05 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 6,677 | $0.8132 | $5,430 | 300,564 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:10 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 21,062 | $2.1658 | $45,615 | 504,241 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:33 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 1,060 | $3.4 | $3,604 | 272,303 (Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:08 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 14,285 | $3.3961 | $48,513 | 373,171 (Direct) | View |
| 2020-02-28 Sale | 2020-03-02 7:28 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 7,050 | $8.7 | $61,335 | 317,756 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 373,300 | $0 | 900,644 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 9:01 pm | N/A 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 200,000 | $0 | 724,344 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:10 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 100,000 | $0 | 387,530 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:10 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 250,000 | $0 | 504,241 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:18 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 10,192 | $0 | 273,363 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:08 pm | N/A 2031-02-26 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 172,000 | $0 | 373,171 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-02 7:28 pm | N/A 2030-02-28 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 167,000 | $0 | 317,756 (Direct) | View |